Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
127 results:

  • 1. Combining pathological risk factors and T, N staging to optimize the assessment for risk stratification and prognostication in low-risk stage III colon cancer.
    Xian ZY; Song YW; Zhang ZJ; Gan YG; Chen YL; Hu T; Wen XF; Mo TW; He XW
    World J Surg Oncol; 2024 Jan; 22(1):10. PubMed ID: 38178080
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Increase in the Life Expectancy of Patients with cancer in the United States.
    Devasia TP; Howlader N; Dewar RA; Stevens JL; Mittu K; Mariotto AB
    Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):196-205. PubMed ID: 38015774
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The clinicopathological spectrum and treatment outcomes in metastatic colorectal cancer in the KwaZulu-Natal province of South Africa.
    Kader S; Moodley Y; Madiba TE
    S Afr J Surg; 2023 Jun; 61(2):86-90. PubMed ID: 37381805
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. WDR54 exerts oncogenic roles in T-cell acute lymphoblastic leukemia.
    Li H; Zhang D; Fu Q; Wang S; Zhang X; Lin Z; Wang Z; Song J; Su Z; Xue V; Liu S; Chen Y; Zhou L; Zhao N; Lu D
    Cancer Sci; 2023 Aug; 114(8):3318-3329. PubMed ID: 37302808
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Bruton's Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials.
    Rozkiewicz D; Hermanowicz JM; Kwiatkowska I; Krupa A; Pawlak D
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903645
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Progress Against cancer in Kuwait: Trends in Incidence, Survival and Mortality.
    E A; A AA; A E; P CM; C A
    Gulf J Oncolog; 2023 Jan; 1(41):23-31. PubMed ID: 36804156
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Studies on 1,4-Quinone Derivatives Exhibiting Anti-Leukemic Activity along with Anti-colorectal and Anti-Breast cancer Effects.
    Ciftci H; Sever B; Kaya N; Bayrak N; Yıldız M; Yıldırım H; Tateishi H; Otsuka M; Fujita M; TuYuN AF
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615273
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Adverse events of endoscopic full-thickness resection: results from the German and Dutch nationwide colorectal FTRD registry.
    Zwager LW; Mueller J; Stritzke B; Montazeri NSM; Caca K; Dekker E; Fockens P; Schmidt A; Bastiaansen BAJ;
    Gastrointest Endosc; 2023 Apr; 97(4):780-789.e4. PubMed ID: 36410447
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study.
    Luo Q; O'Connell DL; Yu XQ; Kahn C; Caruana M; Pesola F; Sasieni P; Grogan PB; Aranda S; Cabasag CJ; Soerjomataram I; Steinberg J; Canfell K
    Lancet Public Health; 2022 Jun; 7(6):e537-e548. PubMed ID: 35660215
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Rectal MRI radiomics inter- and intra-reader reliability: should we worry about that?
    Kwok HC; Charbel C; Danilova S; Miranda J; Gangai N; Petkovska I; Chakraborty J; Horvat N
    Abdom Radiol (NY); 2022 Jun; 47(6):2004-2013. PubMed ID: 35366088
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Liquid Biopsy-based Precision Therapy in Patients with Advanced Solid Tumors: A Real-world Experience from a Community-based Oncology Practice.
    Choucair K; Mattar BI; Van Truong Q; Koeneke T; Van Truong P; Dakhil C; Cannon MW; Page SJ; Deutsch JM; Carlson E; Moore DF; Nabbout NH; Kallail KJ; Dakhil SR; Reddy PS
    Oncologist; 2022 Mar; 27(3):183-190. PubMed ID: 35274713
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Diversion proctocolitis and the problem of the forgotten rectum in inflammatory bowel diseases: A systematic review.
    Dal Buono A; Carvello M; Sachar DB; Spinelli A; Danese S; Roda G
    United European Gastroenterol J; 2021 Dec; 9(10):1157-1167. PubMed ID: 34845854
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The Mitochondrial Disruptor Devimistat (CPI-613) Synergizes with Genotoxic Anticancer Drugs in colorectal cancer Therapy in a Bim-Dependent Manner.
    Arnold C; Demuth P; Seiwert N; Wittmann S; Boengler K; Rasenberger B; Christmann M; Huber M; Brunner T; Linnebacher M; Fahrer J
    Mol Cancer Ther; 2022 Jan; 21(1):100-112. PubMed ID: 34750196
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.
    Stinton C; Jordan M; Fraser H; Auguste P; Court R; Al-Khudairy L; Madan J; Grammatopoulos D; Taylor-Phillips S
    Health Technol Assess; 2021 Jun; 25(42):1-216. PubMed ID: 34169821
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Adverse events associated with nilotinib in chronic myeloid leukemia: mechanisms and management strategies.
    Wang Z; Jiang L; Yan H; Xu Z; Luo P
    Expert Rev Clin Pharmacol; 2021 Apr; 14(4):445-456. PubMed ID: 33618586
    [No Abstract]    [Full Text] [Related]  

  • 17. Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial.
    Kosmala R; Fokas E; Flentje M; Sauer R; Liersch T; Graeven U; Fietkau R; Hohenberger W; Arnold D; Hofheinz RD; Ghadimi M; Ströbel P; Staib L; Grabenbauer GG; Folprecht G; Kirste S; Uter W; Gall C; Rödel C; Polat B;
    Eur J Cancer; 2021 Feb; 144():281-290. PubMed ID: 33383348
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Transcriptomics-Based Characterization of the Toxicity of ZnO Nanoparticles Against Chronic Myeloid Leukemia Cells.
    Alsagaby SA; Vijayakumar R; Premanathan M; Mickymaray S; Alturaiki W; Al-Baradie RS; AlGhamdi S; Aziz MA; Alhumaydhi FA; Alzahrani FA; Alwashmi AS; Al Abdulmonem W; Alharbi NK; Pepper C
    Int J Nanomedicine; 2020; 15():7901-7921. PubMed ID: 33116508
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genomic Analysis of Germline Variation Associated with Survival of Patients with colorectal cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance).
    Innocenti F; Sibley AB; Patil SA; Etheridge AS; Jiang C; Ou FS; Howell SD; Plummer SJ; Casey G; Bertagnolli MM; McLeod HL; Auman JT; Blanke CD; Furukawa Y; Venook AP; Kubo M; Lenz HJ; Parker JS; Ratain MJ; Owzar K
    Clin Cancer Res; 2021 Jan; 27(1):267-275. PubMed ID: 32958699
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical Potentials of miR-576-3p, miR-613, NDRG2 and YKL40 in colorectal cancer Patients.
    Eldaly MN; Metwally FM; Shousha WG; El-Saiid AS; Ramadan SS
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1689-1695. PubMed ID: 32592365
    [TBL] [Abstract] [Full Text] [Related]  


    of 7.